ホーム

Mitomycin C

Mitomycin C

規格

50-07-7CAS番号
200-008-6EC番号
[(4S,6S,7R,8S)-11-amino-7-methoxy-12-methyl-10,13-dioxo-2,5-diazatetracyclo[7.4.0.02,7.04,6]trideca-1(9),11-dien-8-yl]methyl carbamateIUPAC名
C15H18N4O5化学式
334.33 g/mol分子量
mitomycin C; Mitomycin; 50-07-7; Mutamycin; Ametycine; Mitomycin-C; Mitocin-C; Ametycin; Mitomycinum; Mytomycin; Mytozytrex; Mitomycinum C; Mitocin C; Mitamycin; Mitosol; NSC-26980; Muamycin; Mitomycyna C; 7-Amino-9alpha-methoxymitosane; Mito-C; Mitomicina; Mitomycine; DTXSID2020898; NCI-C04706; NSC26980; NSC 26980; JELMYTO; UGN-101; UGN-102; 50SG953SK6; DTXCID00898; [(4S,6S,7R,8S)-11-amino-7-methoxy-12-methyl-10,13-dioxo-2,5-diazatetracyclo[7.4.0.02,7.04,6]trideca-1(9),11-dien-8-yl]methyl carbamate; CHEBI:27504; (1aS,8S,8aR,8bS)-6-Amino-8-[[(aminocarbonyl)oxy]methyl]-1,1a,2,8,8a,8b-hexahydro-8a-methoxy-5-methylazirino[2',3':3,4]pyrrolo[1,2-a]indole-4,7-dione; [(4S,6S,7R,8S)-11-amino-7-methoxy-12-methyl-10,13-dioxo-2,5-diazatetracyclo[7.4.0.0^{2,7}.0^{4,6}]trideca-1(9),11-dien-8-yl]methyl carbamate; Azirino(2',3':3,4)pyrrolo(1,2-a)indole-4,7-dione, 6-amino-1,1a,2,8,8a,8b-hexahydro-8-(hydroxymethyl)-8a-methoxy-5-methyl-, carbamate (ester); Azirino(2',3':3,4)pyrrolo(1,2-a)indole-4,7-dione, 6-amino-8-(((aminocarbonyl)oxy)methyl)-1,1a,2,8,8a,8b-hexahydro-8a-methoxy-5-methyl-, (1aS,8S,8aR,8bS)-; Azirino[2',3':3,4]pyrrolo[1,2-a]indole-4,7-dione, 6-amino-8-[[(aminocarbonyl)oxy]methyl]-1,1a,2,8,8a,8b-hexahydro-8a-methoxy-5-methyl-, (1aS,8S,8aR,8bS)-; MitocinC; Mutamycine; Mitocin; Mitolem; Mitomycine C; Mito-Medac; Mitomycin-X; ((4S,6S,7R,8S)-11-amino-7-methoxy-12-methyl-10,13-dioxo-2,5-diazatetracyclo(7.4.0.0^(2,7).0^(4,6))trideca-1(9),11-dien-8-yl)methyl carbamate; ((4S,6S,7R,8S)-11-amino-7-methoxy-12-methyl-10,13-dioxo-2,5-diazatetracyclo(7.4.0.02,7.04,6)trideca-1(9),11-dien-8-yl)methyl carbamate; (1as,8s,8ar,8bs)-6-amino-8-(((aminocarbonyl)oxy)methyl)-1,1a,2,8,8a,8b-hexahydro-8a-methoxy-5-methylazirino(2',3':3,4)pyrrolo(1,2-a)indole-4,7-dione; RefChem:55655; CHEBI:25357; DTXSID00858942; L01DC03; (1aS,8S,8aR,8bS)-6-Amino-4,7-dioxo-8a-methoxy-5-methyl-1,1a,2,8,8a,8b-hexahydroazirino(2',3':3,4)pyrrolo(1,2-a)indol-8-ylmethyl carbamate; (1aS-(1a alpha,8beta,8a alpha,8b alpha))-6-amino-8-(((aminocarbonyl)oxy)methyl)-1,1a,2,8,8a,8b-hexahydro-8a-methoxy-5-methylazirino(2',3':3,4)pyrrolo(1,2-a)indole-4,7-dione; 200-008-6; Mitozytrex; MMC; Mit-C; RCRA waste number U010; Mitomycyna C [Polish]; MFCD00078109; 6-Amino-1,1a,2,8,8a,8b-hexahydro-8-(hydroxymethyl)-8a-methoxy-5-methylazirino(2',3':3,4)pyrrolo(1,2-a)indole-4,7-dione carbamate (ester); 1404-00-8; CAS-50-07-7; Muamycin (TN); ((1aS,8S,8aR,8bS)-6-amino-8a-methoxy-5-methyl-4,7-dioxo-1,1a,2,4,7,8,8a,8b-octahydroazirino[2',3':3,4]pyrrolo[1,2-a]indol-8-yl)methyl carbamate; [(1aS,8S,8aR,8bS)-6-amino-8a-methoxy-5-methyl-4,7-dioxo-1,1a,2,4,7,8,8a,8b-octahydroazireno[2',3':3,4]pyrrolo[1,2-a]indol-8-yl]methyl carbamate; [(1aS,8S,8aR,8bS)-6-amino-8a-methoxy-5-methyl-4,7-dioxo-1,1a,2,4,7,8,8a,8b-octahydroazirino[2',3':3,4]pyrrolo[1,2-a]indol-8-yl]methyl carbamate; CCRIS 414; HSDB 3239; Mitomycin (USP/INN); MLS002702984; (amino-methoxy-methyl-dioxo-[?]yl)methyl carbamate; EINECS 200-008-6; RCRA waste no. U010; 7-Amino-9.alpha.-methoxymitosane; UNII-50SG953SK6; AI3-26199; Mitomycin CRS; Mitomycin [USAN:USP:INN:BAN]; NCGC00095258-01; Mitomycin; [(1aS,8S,8aR,8bS)-6-Amino-8a-methoxy-5-methyl-4,7-dioxo-1,1a,2,4,7,8,8a,8b-octahydroazirino[2'',3'':3,4]pyrrolo[1,2-a]indol-8-yl]methyl carbamate; Mitomycin C; Jelmyto (TN); ZUSDURI; Azirino(2',3':3,4)pyrrolo(1,2-a)indole-4,7-dione, 6-amino-8-(((aminocarbonyl)oxy)methyl)-1,1a,2,8,8a,8b-hexahydro-8a-methoxy-5-methyl-, (1aS-(1aalpha,8beta,8aalpha,8balpha))-; Mitomycin C from Streptomyces caespitosus; MITOMYCIN [INN]; Mitomycin C (JP18); MITOMYCIN [HSDB]; MITOMYCIN [USAN]; MITOMYCIN [VANDF]; MITOMYCIN C [MI]; CHEMBL105; MITOMYCIN [MART.]; MITOMYCIN C [JAN]; MITOMYCIN [USP-RS]; MITOMYCIN [WHO-DD]; Mitomycin C - High Purity; MITOMYCIN C [IARC]; SCHEMBL3760; CBiol_001927; BSPBio_001267; KBioGR_000607; KBioSS_000607; MLS001332654; orb422198; Mitozytrex (TN) (Supergene); GTPL7089; orb3027145; MITOMYCIN [ORANGE BOOK]; MITOMYCIN [EP MONOGRAPH]; KBio2_000607; KBio2_003175; KBio2_005743; KBio3_001073; KBio3_001074; EX-A501; MITOMYCIN [USP MONOGRAPH]; Mitomycin C - Bio-X trade mark; Bio1_000213; Bio1_000702; Bio1_001191; Bio2_000464; Bio2_000944; HMS1362O09; HMS1792O09; HMS1990O09; HMS2089F16; HMS3403O09; [1aS-(1aalpha,8beta,8aalpha,8balpha)]-6-Amino-8-[[(aminocarbonyl)oxy]methyl]-1,1a,2,8,8a,8b-hexahydro-8a-methoxy-5-methylazirino[2',3':3,4]pyrrolo[1,2-a]indole-4,7-dione; AZIRINO(2',3':3,4)PYRROLO(1,2-A)INDOLE-4,7-DIONE, 6-AMINO-8-(((AMINOCARBONYL)OXY)METHYL)-1,1A,2,8,8A,8B-HEXAHYDRO-8A-METHOXY-5-METHYL-, (1AS-(1A.ALPHA.,8.BETA.,8A.ALPHA.,8B.ALPHA.))-; Tox21_111493; AC-918; BDBM50428658; EBC-26628; GR-311; HB4458; AKOS015895703; Tox21_111493_1; AM26019; CCG-208564; CS-0564; DB00305; KS-5148; IDI1_002219; SMP1_000307; Mitomycin 100 microg/mL in Acetonitrile; NCGC00163468-02; NCGC00163468-03; NCGC00163468-05; NCGC00163468-06; NCGC00163468-11; AM161650; BM164668; HY-13316; SMR000058401; M2320; M3377; NS00004729; T6890; C06681; D00208; D91590; AB00918689-03; AB00918689-04; EN300-7405455; Natural fermentation product from Streptomyces sp.; BRD-K59670716-001-02-6; BRD-K59670716-001-06-7; Q19856779; WLN: T D3 B556 BN EM JV MVTTT&J GO1 H1OVZ KZ L1; Mitomycin C from Streptomyces caespitosus, >=970 mug/mg (USP XXIV); Mitomycin C from Streptomyces caespitosus, powder, BioReagent, suitable for cell culture; Mitomycin C from Streptomyces caespitosus, powder, contains NaCl as solubilizer; Azirino[2',4]pyrrolo[1,2-a]indole-4,7-dione, 6-amino-1,1a,2,8,8a,8b-hexahydro-8-(hydroxymethyl)-8a- methoxy-5-methyl-, carbamate (ester); Azirino[2',4]pyrrolo[1,2-a]indole-4,7-dione, 6-amino-8-[[(aminocarbonyl)oxy]methyl]-1,1a,2,8,8a,8b- hexahydro-8a-methoxy-5-methyl-, [1aR-(1a.alpha.,8.beta.,8a.alpha.,8b.alpha.)]-; Mitomycin C from Streptomyces caespitosus, >=98% (HPLC), potency: >=970 mug per mg (USP XXIV), gamma-irradiated, suitable for cell culture別名